pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2069-2080

  Singh, Ram Pyare ^a   La Cava, Antonio ^a   Hahn, Bevra H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PD1 PROTEIN; PEPTIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BLOCKING ANTIBODY; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; PDCD1 PROTEIN, MOUSE;

ADOLESCENT; AGE DISTRIBUTION; AGED; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GENE SILENCING; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL PROLIFERATION; CONSENSUS SEQUENCE; CROSS BREEDING; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NEW ZEALAND BLACK MOUSE; PATHOLOGY; SPLEEN; SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CONSENSUS SEQUENCE; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; MOLECULAR SEQUENCE DATA; PEPTIDES; SPLEEN; UP-REGULATION;

EID: 42149151044     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2069     Document Type: Article

References (56)

1. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
2. Hahn, B. H. 2001. Lessons in lupus: the mighty mouse. Lupus 10: 589-593.
3. Hahn, B. H., R. R. Singh, W. K. Wong, B. P. Tsao, K. Bulpitt, and F. M. Ebling. 2001. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44: 432-441.
4. 1 mice may influence autoimmunity in the lupus model. Eur. J. Immunol. 34: 2489-2499.
5. 1 mice suppress in vitro production of antibodies to DNA. J. Immunol. 173: 3542-3548.
6. + T cell suppressors. J. Immunol. 175: 7728-7737.
7. + T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 166: 6452-6457.
8. Kang, H. K., and S. K. Datta. 2006. Regulatory T cells in lupus. Int. Rev. Immunol. 25: 5-25.
9. + regulatory T cells in transplantation: progress, challenges, and prospects. Am. J. Transplant. 7: 1457-1463.
10. Kang, H. K., M. Liu, and S. K. Datta. 2007. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory th17 cells. J. Immunol. 178: 7849-7858.
11. Scalapino, K. J., Q. Tang, J. A. Bluestone, M. L. Bonyhadi, and D. I. Daikh. 2006. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177: 1451-1459.
12. Homann, D., and M. von Herrath. 2004. Regulatory T cells and type 1 diabetes. Clin. Immunol. 112: 202-209.
13. + T cells. Nat. Immunol. 7: 475-481.
14. + regulatory T cells and graft-versus-host disease. Semin. Hematol. 43: 62-69.
15. + regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 12: 267-274.
16. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
17. Kang, H. K., M. A. Michaels, B. R. Berner, and S. K. Datta. 2005. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J. Immunol. 174: 3247-3255.
18. + T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. J. Immunol. 178: 7649-7657.
19. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
20. + regulatory T cell activity in both humans and mice. J. Immunol. 172: 834-842.
21. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168: 5979-5983.
22. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
23. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
24. - T cells in an autoimmune disease model. J. Clin. Invest. 112: 1037-1048.
25. + T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172: 1991-1995.
26. - T cells in heart transplant recipients. Hum. Immunol. 64: 31-37.
27. Singh, R. R., F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002. Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169: 587-594.
28. 1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody. J. Clin. Immunol. 20: 268-278.
29. Tsao, B. P., F. M. Ebling, C. Roman, N. Panosian-Sahakian, K. Calame, and B. H. Hahn. 1990. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J. Clin. Invest. 85: 530-540.
30. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458.
31. Shevach, E. M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18: 423-449.
32. + T cells. Adv. Immunol. 81: 331-371.
33. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
34. Horwitz, D. A., J. D. Gray, and S. G. Zheng. 2002. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. 4: 241-246.
35. Horwitz, D. A., S. G. Zheng, J. D. Gray, J. H. Wang, K. Ohtsuka, and S. Yamagiwa. 2004. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16: 135-143.
36. + regulatory T lymphocytes in neonatal NOD mice. Ann. NY Acad. Sci. 1051: 72-87.
37. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
38. + precursors. Am. J. Transplant. 4: 1614-1627.
39. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
40. + regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200: 1123-1134.
41. + T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transplant Immunol. 13: 239-247.
42. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237-243.
43. Jiang, S., S. Tugulea, G. Pennesi, Z. Liu, A. Mulder, S. Lederman, P. Harris, R. Cortesini, and N. Suciu-Foca. 1998. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59: 690-699.
44. 1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase. Clin. Immunol. 117: 262-270.
45. Sela, U., N. Mauermann, R. Hershkoviz, H. Zinger, M. Dayan, L. Cahalon, J. P. Liu, E. Mozes, and O. Lider. 2005. The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-β-mediated suppression of LFA-1 and CD44 expression and function. J. Immunol. 175: 7255-7263.
46. Sharabi, A., A. Haviv, H. Zinger, M. Dayan, and E. Mozes. 2006. Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis. Clin. Immunol. 119: 146-155.
47. H-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 196: 731-741.
48. + cytolytic T cells. J. Immunol. 178: 3566-3574.
49. Okazaki, T., and T. Honjo. 2006. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27: 195-201.
50. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
51. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
52. Keir, M. E., L. M. Francisco, and A. H. Sharpe. 2007. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19: 309-314.
53. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403.
54. Goldberg, M. V., C. H. Maris, E. L. Hipkiss, A. S. Flies, L. Zhen, R. M. Tuder, J. F. Grosso, T. J. Harris, D. Getnet, K. A. Whartenby, et al. 2007. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 110: 186-192.
55. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
56. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16: 1055-1068.